These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 24288761)

  • 1. Polymeric complexes of isonicotinic acid hydrazide with antituberculosis effects.
    Slivkin AI; Lapenko VL; Bychuk AI; Suslina SN; Slivkin DA; Kornienko SV; Belenova AS
    Bull Exp Biol Med; 2013 Oct; 155(6):764-6. PubMed ID: 24288761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental data on the antimicrobial activity of Isoprodian (PTH).
    Urbanczik R
    Scand J Respir Dis Suppl; 1978; 102():58-9. PubMed ID: 98838
    [No Abstract]   [Full Text] [Related]  

  • 3. Preparation and antitubercular activities in vitro and in vivo of novel Schiff bases of isoniazid.
    Hearn MJ; Cynamon MH; Chen MF; Coppins R; Davis J; Joo-On Kang H; Noble A; Tu-Sekine B; Terrot MS; Trombino D; Thai M; Webster ER; Wilson R
    Eur J Med Chem; 2009 Oct; 44(10):4169-78. PubMed ID: 19524330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential of Casiopeínas® Copper Complexes and Antituberculosis Drug Combination against Mycobacterium tuberculosis.
    Barbosa AR; Caleffi-Ferracioli KR; Leite CQ; García-Ramos JC; Toledano-Magaña Y; Ruiz-Azuara L; Siqueira VL; Pavan FR; Cardoso RF
    Chemotherapy; 2016; 61(5):249-55. PubMed ID: 26950478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and mechanistic investigation of iron(II) complexes of isoniazid and derivatives as a redox-mediated activation strategy for anti-tuberculosis therapy.
    Laborde J; Deraeve C; de Mesquita Vieira FG; Sournia-Saquet A; Rechignat L; Villela AD; Abbadi BL; Macchi FS; Pissinate K; Bizarro CV; Machado P; Basso LA; Pratviel G; de França Lopes LG; Sousa EHS; Bernardes-Génisson V
    J Inorg Biochem; 2018 Feb; 179():71-81. PubMed ID: 29175704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hixozide, a novel combined antituberculosis preparation].
    Glushkov RG; Sokolova GB
    Antibiot Khimioter; 2008; 53(5-6):11-3. PubMed ID: 19069176
    [No Abstract]   [Full Text] [Related]  

  • 7. Novel isoniazid derivative as promising antituberculosis agent.
    Volynets GP; Tukalo MA; Bdzhola VG; Derkach NM; Gumeniuk MI; Tarnavskiy SS; Yarmoluk SM
    Future Microbiol; 2020 Jul; 15(10):869-879. PubMed ID: 32662670
    [No Abstract]   [Full Text] [Related]  

  • 8. Isoniazid-resistant disseminated Mycobacterium tuberculosis in a Jamaican infant with HIV/AIDS.
    Singh-Minott I; Pierre RB; Olugbuyi O; Dunkley-Thompson J; Haughton D; Christie CD
    West Indian Med J; 2008 Jun; 57(3):298-301. PubMed ID: 19583132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Reasons for drug-resistant tuberculosis emergence].
    Tu DH
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):403-5. PubMed ID: 17673006
    [No Abstract]   [Full Text] [Related]  

  • 10. [The influence of the simultaneous administration of 5-bromosalicylohydroxamic acid (T-40) and isonicotinic acid hydrazide on the concentration of free isonicotinic acid hydrazide in the urine of patients with pulmonary tuberculosis].
    Zduńczyk-Pawelek H; Otrzonsek N; Kostrzewska K
    Gruzlica; 1965 May; 33(5):411-5. PubMed ID: 5319220
    [No Abstract]   [Full Text] [Related]  

  • 11. Location of Pulmonary Mycobacteria Tuberculosis and Effectiveness of Various Dextrazide Compositions in Treatment of Mice with BCG-Induced Granulomatosis.
    Sinyavskaya AM; Shkurupy VA; Troitskiy AV; Kovner AM
    Bull Exp Biol Med; 2020 May; 169(1):63-66. PubMed ID: 32495171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the efficiency of activity of the liposomal form of isoniazid against different types of mycobacteria in vitro].
    Golyshevskaia VI; Selishcheva AA; Martynova LP; Lepekha LN; Kalashnikova TM; Kornilova ZKh; Erokhin VV; Rozenberg OA
    Probl Tuberk Bolezn Legk; 2006; (8):61-4. PubMed ID: 17002062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacteriologic basis of short-course chemotherapy for tuberculosis.
    Grosset J
    Clin Chest Med; 1980 May; 1(2):231-41. PubMed ID: 6794976
    [No Abstract]   [Full Text] [Related]  

  • 14. Antitubercular activity of Ru (II) isoniazid complexes.
    Aguiar Id; Tavares A; Roveda AC; da Silva AC; Marino LB; Lopes ÉO; Pavan FR; Lopes LG; Franco DW
    Eur J Pharm Sci; 2015 Apr; 70():45-54. PubMed ID: 25638418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of new antituberculosis drugs in mouse models.
    Davies GR; Pym AS; Mitchison DA; Nuermberger EL; Grosset JH
    Antimicrob Agents Chemother; 2007 Jan; 51(1):403; author reply 403-4. PubMed ID: 17182861
    [No Abstract]   [Full Text] [Related]  

  • 16. Cuprous complexes formed with isonicotinic hydrazide.
    Krivis AF; Rabb JM
    Science; 1969 May; 164(3883):1064-5. PubMed ID: 4976919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of copper(II) complexes with isoniazid-derived hydrazones as anticancer and antitubercular agents.
    Firmino GS; de Souza MV; Pessoa C; Lourenco MC; Resende JA; Lessa JA
    Biometals; 2016 Dec; 29(6):953-963. PubMed ID: 27591998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antituberculosis properties of methyldioxotetrahydropyrimidine sulfonisonicotinoyl hydrazide].
    Kibrik BS; Chelnokova OG; Terekhina LM; Sosnina OIu
    Antibiot Khimioter; 2012; 57(11-12):16-21. PubMed ID: 23700932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based design of some isonicotinic acid hydrazide analogues as potential antitubercular agents.
    Atta A; Fahmy S; Rizk O; Sriram D; Mahran MA; Labouta IM
    Bioorg Chem; 2018 Oct; 80():721-732. PubMed ID: 30077175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the potential role of a new mutation in mabA in modifying the response of Mycobacterium tuberculosis to isoniazid.
    Alonso M; Martínez-Lirola M; Palacios JJ; Menéndez Á; Herranz M; Martínez S; Bouza E; García-de-Viedma D
    Tuberculosis (Edinb); 2013 Nov; 93(6):664-7. PubMed ID: 23973657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.